by EmpathiCSubstanceS | Feb 2, 2022 | Bipolar Disorder, LSD, MDMA Sassafras Molly, OCD, Pain, Psilocybin Magic Mushroom
On 5 May 1953 the novelist Aldous Huxley dissolved four-tenths of a gram of mescaline in a glass of water, drank it, then sat back and waited for the drug to take effect. Huxley consumed the drug in his California home under the direct supervision of psychiatrist...
by EmpathiCSubstanceS | Jan 14, 2022 | LSD, MDMA Sassafras Molly, Microdosing, Neuropathy, NN-Dimethyltryptamine, OCD, Pain, Parkinson's Disease
Another myth being commercialized is that psychedelic drugs will make you a peaceful, righteous human. The notion that the world’s problems would be solved if more people took entheogens is a hallucination in and of itself. However, there are countless examples of...
by EmpathiCSubstanceS | Jan 14, 2022 | Cluster Headaches, Depression, DMT, Kambo, LSD
The main focus on naturally occurring psychedelics has been on a few dozen species identified in North and South America. For example, the Western world knows of roughly 100 species of psychedelic mushrooms. Is this a bias from our bioprospecting or a true...
by EmpathiCSubstanceS | Jan 14, 2022 | Cancer, Cannabis Marijuana, Chronic Pain, Depression, LSD, Neuropathy, Pain, Psychotropics
A first-of-its-kind clinical trial has pitted a common antidepressant against psilocybin, the main psychedelic compound found in magic mushrooms. The results, recently published in the New England Journal of Medicine, are decidedly mixed with the primary depression...
by EmpathiCSubstanceS | Jan 13, 2022 | CBC, Cluster Headaches, DMT, Iboga, Kambo, LSD, MDMA Sassafras Molly, Neuropathy, OCD, Parkinson's Disease
Basic and clinical studies demonstrate that depression is associated with reduced size of brain regions that regulate mood and cognition, including the prefrontal cortex and the hippocampus, and decreased neuronal synapses in these areas. Antidepressants can block or...
by EmpathiCSubstanceS | Jan 13, 2022 | Chronic Pain, Depression, Iboga, Kambo, LSD, MDMA Sassafras Molly, Pain, Parkinson's Disease
Perhaps one of the most important psychedelic science articles published in 2021 came when psychopharmacologist Suresh Muthukumaraswamy and colleagues Anna Forsythe and Thomas Lumley called out the big elephant in the room of psychedelic clinical trials. The...
